|
|
Article: MicroPhage Successfully Completes Beta Trial for Rapid MRSA Test.(Clinical report)
- Article from:
- Biotech Week
- Article date:
- January 28, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A new bacterial identification test that rapidly identifies MRSA infections moved closer to market with conclusion of its first multicenter clinical trial, which was announced by MicroPhage, Inc., http://www.microphage.com/. The company also reported the trial results have surpassed its early-stage performance expectations (see also Drug Resistance).
The beta-site study evaluated MicroPhage's prototype assay to identify Staphylococcus aureus (staph) bacteria and determine methicillin resistance (MRSA) or susceptibility (MSSA) in suspected cases of bacteremia (bacteria in the blood). The research precedes FDA-submission clinical studies, which are scheduled to ...